ABVC BioPharma, Inc. Related Party Transaction, Amounts of Transaction
ABVC BioPharma, Inc. (ABVC) reported Related Party Transaction, Amounts of Transaction of $59.41 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-18.
Financial Statements › Notes › Related Party Transactions
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2026-05-18
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for the quarter ending 2026-03-31 was $59.41K, a 12.82% decline year-over-year.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for the quarter ending 2025-12-31 was $30.82K, a 776.45% increase year-over-year.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for the quarter ending 2025-09-30 was $60.35K, a 40.02% increase year-over-year.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for the quarter ending 2025-06-30 was $57.44K, a 0.42% decline year-over-year.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for fiscal 2025 was $219.99K, a 111.36% increase from fiscal 2024.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for fiscal 2024 was $104.08K, a 29.61% decline from fiscal 2023.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for fiscal 2023 was $147.88K, a 21.66% decline from fiscal 2022.
- ABVC BioPharma, Inc. related party transaction, amounts of transaction for fiscal 2022 was $188.75K.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|
| 2026-03-31 | $59.41K 10-Q · filed 2026-05-18 | $90.22K derived: sum of 2 quarters · filed 2026-05-18 | $150.57K derived: sum of 3 quarters · filed 2026-05-18 | $208.01K derived: sum of 4 quarters · filed 2026-05-18 |
| 2025-12-31 | $30.82K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $91.16K derived: sum of 2 quarters · filed 2026-03-03 | $148.60K derived: sum of 3 quarters · filed 2026-03-03 | $219.99K 10-K · filed 2026-03-03 |
| 2025-09-30 | $60.35K 10-Q/A · filed 2026-03-03 | $117.79K derived: sum of 2 quarters · filed 2026-03-03 | $189.18K 10-Q/A · filed 2026-03-03 | $189.45K derived: sum of 4 quarters · filed 2026-05-18 |
| 2025-06-30 | $57.44K 10-Q · filed 2025-08-13 | $126.02K 10-Q · filed 2025-08-13 | $129.10K derived: sum of 3 quarters · filed 2026-05-18 | $172.20K derived: sum of 4 quarters · filed 2026-05-18 |
| 2025-03-31 | $68.14K 10-Q · filed 2026-05-18 | $71.66K derived: sum of 2 quarters · filed 2026-05-18 | $114.76K derived: sum of 3 quarters · filed 2026-05-18 | $172.44K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $3.52K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $46.62K derived: sum of 2 quarters · filed 2026-03-03 | $104.30K derived: sum of 3 quarters · filed 2026-03-03 | $104.08K 10-K · filed 2026-03-03 |
| 2024-09-30 | $43.10K 10-Q/A · filed 2026-03-03 | $100.78K derived: sum of 2 quarters · filed 2026-03-03 | $100.57K 10-Q/A · filed 2026-03-03 | -$52.66K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $57.68K 10-Q · filed 2025-08-13 | $75.86K 10-Q · filed 2025-08-13 | -$95.76K derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $14.63K 10-Q · filed 2025-04-30 | -$153.44K derived: sum of 2 quarters · filed 2025-04-30 | ||
| 2023-12-31 | -$168.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $147.88K 10-K · filed 2024-03-13 | ||
| 2023-09-30 | $315.95K 10-Q · filed 2023-11-15 | |||
| 2023-03-31 | $88.09K 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $188.75K 10-K · filed 2024-03-13 |